• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

covid19.healthcare.pro
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home DermConnect Example PRES

Tag Archive

  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    Factors ID’d for Strong Antibody Response in COVID-19

    View Post
  • COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    COVID-19 Pandemic Challenges Osteoporosis Management

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 26, 2020

    AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy / October 23, 2020

    Survival From COVID-19 High in Patients With Psoriasis

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 23, 2020

    FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    View Post
View Post

FDA Advisers Back Full Approval of Paxlovid

In COVID-19, Latest News
by Healthday
March 17, 2023

Panel of FDA advisers says the medication remains safe and effective for high-risk patients

View Post

Viral, Symptom Rebound Common After COVID-19 Infection

In COVID-19, Latest News
by Healthday
March 9, 2023

Incidence of symptom rebound was higher in the nirmatrelvir plus ritonavir treatment group

View Post

Feds Will Start Limiting Telehealth Prescriptions for Painkillers, ADHD Drugs

In COVID-19, Latest News
by Healthday
February 27, 2023

Patients will be required to see a doctor in person to get a first prescription for opioids, ADHD drugs

View Post

Pegylated Interferon Lambda Effective in Preventing Severe COVID-19

In COVID-19, Latest News
by Healthday
February 9, 2023

Incidence of hospitalization or emergency department visit lower for those receiving interferon versus placebo

View Post

No Increase Seen in OD Deaths Involving Buprenorphine During COVID-19

In COVID-19, Latest News
by Healthday
January 23, 2023

Proportion of overdose deaths did not increase in association with actions taken to ease access to buprenorphine

View Post

Fluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19

In COVID-19, Latest News
by Healthday
January 12, 2023

No difference seen for fluvoxamine, placebo in composite outcome of hospitalization, urgent care visit, emergency department visit, death

View Post

VV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19

In COVID-19, Latest News
by Healthday
January 6, 2023

Noninferiority established with respect to time to sustained clinical recovery for adults at high risk for progression

View Post

Molnupiravir Does Not Reduce COVID-19-Related Hospitalization, Death

In COVID-19, Latest News
by Healthday
December 29, 2022

No reduction in COVID-19-associated hospitalizations or deaths seen among high-risk, vaccinated adults

View Post

Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors

In COVID-19, Latest News
by Healthday
December 12, 2022

Reduced risks for hospitalization and death observed for mainly vaccinated outpatients aged 50 years or older with COVID-19

View Post

Fewer Buprenorphine Initiation Episodes Seen During Pandemic

In COVID-19, Latest News
by Healthday
December 9, 2022

Number of active buprenorphine episodes comparable to expected number, with fewer initiations and fewer ending of episodes

  • Page 1 of 17
  • 1
  • 2
  • 3
  • ...
  • 17
  • →

TRENDING

  • Pattern of Early Identification of Autism Reversed After Pandemic
  • Tuberculosis Patients Increasing 5% in the U.S.
  • Is Kentucky Protected from Measles
  • 1.9 million Children Receiving Yellow Fever Vaccination
  • More Testing of Staff Linked to Drop in COVID-19 Cases, Deaths at SNFs

By Publish Date

March 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Feb    

LATEST ARTICLES

  • Pattern of Early Identification of Autism Reversed After Pandemic March 24, 2023
  • Tuberculosis Patients Increasing 5% in the U.S. March 23, 2023
  • Is Kentucky Protected from Measles March 23, 2023

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines